首页> 外文OA文献 >Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: a prospective cohort study
【2h】

Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: a prospective cohort study

机译:体外膀胱切除术与体内导流对低心肺健康患者的益处:一项前瞻性队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: ududPatients undergoing radical cystectomy have associated comorbidities resulting in reduced cardiorespiratory fitness. Preoperative cardiopulmonary exercise testing (CPET) measures including anaerobic threshold (AT) can predict major adverse events (MAE) and hospital length of stay (LOS) for patients undergoing open and robotic cystectomy with extracorporeal diversion. Our objective was to determine the relationship between CPET measures and outcome in patients undergoing robotic radical cystectomy and intracorporeal diversion (intracorporeal robotic assisted radical cystectomy [iRARC]).ududMethods: ududA single institution prospective cohort study in patients undergoing iRARC for muscle invasive and high-grade bladder cancer. Inclusion: patients undergoing standardised CPET before iRARC. Exclusions: patients not consenting to data collection. Data on CPET measures (AT, ventilatory equivalent for carbon dioxide [VE/VCO2] at AT, peak oxygen uptake [VO2]), and patient demographics prospectively collected. Outcome measurements included hospital LOS; 30-day MAE and 90-day mortality data, which were prospectively recorded. Descriptive and regression analyses were used to assess whether CPET measures were associated with or predicted outcomes.ududResults: ududFrom June 2011 to March 2015, 128 patients underwent radical cystectomy (open cystectomy, n = 17; iRARC, n = 111). A total of 82 patients who underwent iRARC and CPET and consented to participation were included. Median (interquartile range): age = 65 (58–73); body mass index = 27 (23–30); AT = 10.0 (9–11), Peak VO2 = 15.0 (13–18.5), VE/VCO2 (AT) = 33.0 (30–38). 30-day MAE = 14/111 (12.6%): death = 2, multiorgan failure = 2, abscess = 2, gastrointestinal = 2, renal = 6; 90-day mortality = 3/111 (2.7%). AT, peak VO2, and VE/VCO2 (at AT) were not significant predictors of 30-day MAE or LOS. The results are limited by the absence of control group undergoing open surgery.ududConclusions: ududPoor cardiorespiratory fitness does not predict increased hospital LOS or MAEs in patients undergoing iRARC. Overall, MAE and LOS comparable with other series.
机译:背景:接受根治性膀胱切除术的患者具有相关合并症,导致心肺适应性降低。术前心肺运动测试(CPET)措施(包括无氧阈值(AT))可以预测接受开放式和机器人膀胱切除术并进行体外转移的患者的主要不良事件(MAE)和住院时间(LOS)。我们的目标是确定接受机器人根治性膀胱切除术和体内转移(体内机器人辅助根治性膀胱切除术[iRARC])的患者的CPET指标与结果之间的关系。 ud ud方法: ud ud针对接受iRARC的患者进行的单机构前瞻性队列研究用于肌肉浸润性和高级膀胱癌。纳入:在iRARC之前接受标准化CPET的患者。排除:患者不同意数据收集。有关CPET量度的数据(AT,AT处的二氧化碳通气当量[VE / VCO2],最大摄氧量[VO2])和预期患者的人口统计数据。结果测量包括医院LOS。前瞻性记录30天MAE和90天死亡率。结果使用 ud ud进行描述性和回归分析,以评估CPET措施是否与预后相关或预测的结果。 ud ud从2011年6月至2015年3月,有128例患者接受了根治性膀胱切除术(开放性膀胱切除术,n = 17; iRARC,n = 111)。共有82例接受了iRARC和CPET并同意参与的患者。中位数(四分位数间距):年龄= 65(58-73);体重指数= 27(23–30); AT = 10.0(9–11),峰值VO2 = 15.0(13–18.5),VE / VCO2(AT)= 33.0(30–38)。 30天MAE = 14/111(12.6%):死亡= 2,多器官衰竭= 2,脓肿= 2,胃肠道= 2,肾= 6; 90天死亡率= 3/111(2.7%)。 AT,VO2峰值和VE / VCO2(AT)不是30天MAE或LOS的重要预测指标。结果受到缺乏进行开放手术的对照组的限制。 ud ud结论: ud ud心肺适应性差不能预测接受iRARC的患者的住院LOS或MAE升高。总体而言,MAE和LOS可与其他系列媲美。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号